As a reminder, today is the final day of our Ask Stanford Med installment focused on breast cancer. Questions related to breast cancer screening, dense breast notification legislation and advances in diagnostics and therapies can be submitted to Stanford surgeon Fredrick Dirbas, MD, by either sending a tweet that includes the hashtag #AskSUMed or posting your question in the comments section of our previous entry. We'll accept questions until 5 p.m. Pacific time.
We provided details about Dirbas' clinical work and research in our earlier post:
As head of the Breast Disease Management Group at the Stanford Women’s Cancer Center, Dirbas works with an interdisciplinary team of radiologists, oncologists, pathologists, researchers and support programs to provide patients with a comprehensive treatment approach. His research focuses on improving breast cancer therapy by refining existing diagnostic and treatment options and introducing new methods that reduce side effects and improve patients’ quality of life.
A 2011 Stanford Hospital Health Notes article describes how Dirbas and colleagues are at the forefront of exploring new ideas for delivering radiation in a more targeted and accelerated fashion, including methods such as intraoperative radiotherapy and another approach using external radiation therapy after surgery.
Previously: Ask Stanford Med: Surgeon taking questions on breast cancer diagnostics and therapies, California’s new law on dense breast notification: What it means for women and Five days instead of five weeks: A less-invasive breast cancer therapy
Photo by Wellcome Images
